Changes to the Code
H.R. 2197 · No 340B Savings for Transgender Care Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
42 U.S.C. § 256b Limitation on prices of drugs purchased by covered entities
+12 −0Shown
1 change the bill asks for here, 1 carried out
- Carried out:
Section 340B(a)(4) of the Public Health Service Act (42 U.S.C. 256b(a)(5)) is amended by adding at the end the following:
(E) Prohibition on use of 340b savings for services described.— A covered entity participating in the program under this section may not use any funds derived from the difference between the 340B ceiling price and the actual acquisition cost of covered outpatient drugs to pay …
§ 256b(a)Requirements for agreement with Secretary(5)–(7)
Start of § 256b to (a)(5)(B) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (5)(C) | (C) Auditing | (C) Auditing | ||
| A covered entity shall permit the Secretary and the manufacturer of a covered outpatient drug that is subject to an agreement under this subsection with the entity (acting in accordance with procedures established by the Secretary relating to the number, duration, and scope of audits) to audit at the Secretary’s or the manufacturer’s expense the records of the entity that directly pertain to the entity’s compliance with the requirements described in subparagraphs2 (A) or (B) with respect to drugs of the manufacturer. | A covered entity shall permit the Secretary and the manufacturer of a covered outpatient drug that is subject to an agreement under this subsection with the entity (acting in accordance with procedures established by the Secretary relating to the number, duration, and scope of audits) to audit at the Secretary’s or the manufacturer’s expense the records of the entity that directly pertain to the entity’s compliance with the requirements described in subparagraphs2 (A) or (B) with respect to drugs of the manufacturer. | |||
| (5)(D) | (D) Additional sanction for noncompliance | (D) Additional sanction for noncompliance | ||
| If the Secretary finds, after audit as described in subparagraph (C) and after notice and hearing, that a covered entity is in violation of a requirement described in subparagraphs 2 (A) or (B), the covered entity shall be liable to the manufacturer of the covered outpatient drug that is the subject of the violation in an amount equal to the reduction in the price of the drug (as described in subparagraph (A)) provided under the agreement between the entity and the manufacturer under this paragraph. | If the Secretary finds, after audit as described in subparagraph (C) and after notice and hearing, that a covered entity is in violation of a requirement described in subparagraphs 2 (A) or (B), the covered entity shall be liable to the manufacturer of the covered outpatient drug that is the subject of the violation in an amount equal to the reduction in the price of the drug (as described in subparagraph (A)) provided under the agreement between the entity and the manufacturer under this paragraph. | |||
| (5)(E) | (E) [inserted: Prohibition on use of 340b savings for services described.—] | |||
| [inserted: A covered entity participating in the program under this section may not use any funds derived from the difference between the 340B ceiling price and the actual acquisition cost of covered outpatient drugs to pay for services described.] | ||||
| (5)(E)(i) | (i) [inserted: Definitions.—] | |||
| [inserted: For purposes of this subsection—] | ||||
| (5)(E)(i)(I) | (I) [inserted: Covered entity.—] | |||
| [inserted: The term “covered entities” has the meaning given such term in section 340B(a)(4).] | ||||
| (5)(E)(i)(II) | (II) [inserted: Services described.—] | |||
| [inserted: The term “services described” means—] | ||||
| (5)(E)(i)(II)(aa) | (aa) [inserted: ] | |||
| [inserted: sex reassignment surgeries furnished for the purpose of the gender alteration of a transgender individual; and] | ||||
| (5)(E)(i)(II)(bb) | (bb) [inserted: ] | |||
| [inserted: hormone treatments furnished for the purpose of the gender alteration of a transgender individual.] | ||||
| (6) | (6) Treatment of distinct units of hospitals | (6) Treatment of distinct units of hospitals | ||
| In the case of a covered entity that is a distinct part of a hospital, the hospital shall not be considered a covered entity under this paragraph unless the hospital is otherwise a covered entity under this subsection. | In the case of a covered entity that is a distinct part of a hospital, the hospital shall not be considered a covered entity under this paragraph unless the hospital is otherwise a covered entity under this subsection. | |||
| (7) | (7) Certification of certain covered entities | (7) Certification of certain covered entities | ||
Rest of § 256b unchanged